Improved predictability of extracapsular extension and seminal vesicle involvement based on clinical and biopsy findings in prostate cancer in Japanese men

被引:49
作者
Egawa, S
Suyama, K
Matsumoto, K
Satoh, T
Uchida, T
Kuwao, S
Koshiba, K
机构
[1] Kitasato Univ, Sch Med, Dept Urol, Kanagawa 2288555, Japan
[2] Kitasato Univ, Sch Med, Dept Pathol, Kanagawa 2288555, Japan
关键词
D O I
10.1016/S0090-4295(98)00207-6
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives. The accurate preoperative prediction of the extent of cancer by pathologic examination is essential for choosing the optimal treatment for patients with prostate cancer. Currently available clinical staging methods are not adequate and more precise staging is required. Methods. Using the log likelihood ratio test and receiver operating characteristic (ROC) curve analysis, preoperative variables, including biopsy pathologic findings, were assessed for predicting final pathologic stage in prostate cancer. A multivariate model for predicting disease organ confinement status was established for easy clinical use. Results. The use of the number of cores with cancer and maximum cancer length in conjunction with the three variables (prostate-specific antigen, clinical stage, and biopsy Gleason score) was found to significantly improve predictability of extracapsular extension and seminal vesicle involvement in clinically resectable (n = 96) and localized prostate cancers (n = 81) (P <0.05). Areas under ROC curves for the above two parameter sets (five- versus three-variable model) were 0.8395 and 0.7109, respectively, for capacity for extracapsular extension prediction in clinically localized cancer. These values for seminal vesicle involvement were 0.7861 and 0.6927, respectively. The logistic model gave positive and negative predictive Values of 73% and 78%, and 64% and 83%, respectively, for extracapsular extension and seminal vesicle involvement in clinically localized cancer at a predicted probability of 0.5 or greater. Conclusions. The present method may be used to predict non-organ-confined prostate cancer with greater accuracy than the previously reported model using three variables. UROLOGY 52: 433-440, 1998. (C) 1998, Elsevier Science Inc. All rights reserved.
引用
收藏
页码:433 / 440
页数:8
相关论文
共 27 条
  • [1] ANALYSIS OF RISK-FACTORS ASSOCIATED WITH PROSTATE-CANCER EXTENSION TO THE SURGICAL MARGIN AND PELVIC NODE METASTASIS AT RADICAL PROSTATECTOMY
    ACKERMAN, DA
    BARRY, JM
    WICKLUND, RA
    OLSON, N
    LOWE, BA
    [J]. JOURNAL OF UROLOGY, 1993, 150 (06) : 1845 - 1850
  • [2] [Anonymous], 1992, CAMBELLS UROLOGY
  • [3] [Anonymous], 1997, TNM CLASSIFICATION M
  • [4] An algorithm for predicting nonorgan confined prostate cancer using the results obtained from sextant core biopsies with prostate specific antigen level
    Badalament, RA
    Miller, MC
    Peller, PA
    Young, DC
    Bahn, DK
    Kochie, P
    ODowd, GJ
    Veltri, RW
    [J]. JOURNAL OF UROLOGY, 1996, 156 (04) : 1375 - 1380
  • [5] ELIMINATING THE NEED FOR BILATERAL PELVIC LYMPHADENECTOMY IN SELECT PATIENTS WITH PROSTATE-CANCER
    BLUESTEIN, DL
    BOSTWICK, DG
    BERGSTRALH, EJ
    OESTERLING, JE
    [J]. JOURNAL OF UROLOGY, 1994, 151 (05) : 1315 - 1320
  • [6] Prediction of capsular perforation and seminal vesicle invasion in prostate cancer
    Bostwick, DG
    Qian, JQ
    Bergstralh, E
    Dundore, P
    Dugan, J
    Myers, RP
    Oesterling, JE
    [J]. JOURNAL OF UROLOGY, 1996, 155 (04) : 1361 - 1367
  • [7] NERVE-SPARING RADICAL PROSTATECTOMY - EVALUATION OF RESULTS AFTER 250 PATIENTS
    CATALONA, WJ
    BIGG, SW
    [J]. JOURNAL OF UROLOGY, 1990, 143 (03) : 538 - 544
  • [8] THE VOLUME OF PROSTATE-CANCER IN THE BIOPSY SPECIMEN CANNOT RELIABLY PREDICT THE QUANTITY OF CANCER IN THE RADICAL PROSTATECTOMY SPECIMEN ON AN INDIVIDUAL BASIS
    CUPP, MR
    BOSTWICK, DG
    MYERS, RP
    OESTERLING, JE
    [J]. JOURNAL OF UROLOGY, 1995, 153 (05) : 1543 - 1548
  • [9] Preoperative serum prostate-specific antigen, clinical stage and Gleason sum as basis for predicting final pathological stage Japanese patients with prostate cancer
    Egawa, S
    Koh, H
    Satoh, T
    Ohori, M
    Uchida, T
    Kuwao, S
    Koshiba, K
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1996, 26 (06) : 438 - 444
  • [10] PATHOLOGICAL AND CLINICAL FINDINGS TO PREDICT TUMOR EXTENT OF NONPALPABLE (STAGE-T1C) PROSTATE-CANCER
    EPSTEIN, JI
    WALSH, PC
    CARMICHAEL, M
    BRENDLER, CB
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (05): : 368 - 374